Trials / Enrolling By Invitation
Enrolling By InvitationNCT05233111
Brief Prolonged Exposure Therapy Versus Clinical Standard to Reduce Posttraumatic Stress Post Spinal Cord Injury
Prevention of Posttraumatic Stress: A RCT of Modified Brief Prolonged Exposure Therapy (Brief PE) During Inpatient Rehabilitation Post Spinal Cord Injury (SCI)
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Baylor Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine the use brief prolonged exposure (Brief PE) therapy compared to standard clinical care to reduce posttraumatic distress among people who have had a spinal cord injury and are receiving rehabilitation in an inpatient setting.
Detailed description
This is a prospective randomized controlled trial examining the efficacy of brief Prolonged Exposure Therapy (Brief PE) delivered in an inpatient rehabilitation setting post-SCI to reduce PTSD symptoms. The overall goal of this project is to test a Brief PE (three 60-minute sessions) to reduce psychological distress after SCI and to mitigate long-term post-SCI distress including PTSD as well as secondary health outcomes (including depression and general anxiety) at 1, 3, and 6 months from baseline. The intervention group (Brief PE) will be compared to standard clinical care with treatment as usual (TAU).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Brief Prolonged Exposure Therapy | Brief PE will include 3 therapy sessions, each lasting approximately 60 minutes. |
| BEHAVIORAL | Treatment as Usual | This may include an evaluation by a licensed psychologist and continued follow-up psychotherapy as needed. Treatment as usual participants will have follow-up assessments at 1, 3, and 6 months. |
Timeline
- Start date
- 2022-02-07
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2022-02-10
- Last updated
- 2026-01-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05233111. Inclusion in this directory is not an endorsement.